Houzong Yao

1.2k total citations
24 papers, 732 citations indexed

About

Houzong Yao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Houzong Yao has authored 24 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Organic Chemistry. Recurrent topics in Houzong Yao's work include Advanced biosensing and bioanalysis techniques (8 papers), Metal complexes synthesis and properties (6 papers) and Ferrocene Chemistry and Applications (4 papers). Houzong Yao is often cited by papers focused on Advanced biosensing and bioanalysis techniques (8 papers), Metal complexes synthesis and properties (6 papers) and Ferrocene Chemistry and Applications (4 papers). Houzong Yao collaborates with scholars based in China, Hong Kong and France. Houzong Yao's co-authors include Ge Zhang, Aiping Lü, Feng Jiang, Jun Lü, Guangyu Zhu, Lili Wang, Shuaijian Ni, Shu Chen, Man‐Kit Tse and Zhiqin Deng and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and International Journal of Molecular Sciences.

In The Last Decade

Houzong Yao

22 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houzong Yao China 12 419 207 166 132 123 24 732
Larisa Kuznetsova United States 5 372 0.9× 132 0.6× 202 1.2× 120 0.9× 167 1.4× 5 750
Mandana T. Manzari United States 5 344 0.8× 99 0.5× 361 2.2× 124 0.9× 68 0.6× 8 821
Mohamed Wehbe Canada 17 337 0.8× 231 1.1× 183 1.1× 76 0.6× 130 1.1× 26 746
Matteo Ardini Italy 16 314 0.7× 103 0.5× 135 0.8× 126 1.0× 47 0.4× 34 656
Huailei Ma China 9 600 1.4× 274 1.3× 337 2.0× 93 0.7× 49 0.4× 13 1.0k
A.M. Thomas India 14 535 1.3× 353 1.7× 140 0.8× 81 0.6× 201 1.6× 21 967
Andreas F. B. Räder Germany 11 509 1.2× 177 0.9× 129 0.8× 33 0.3× 196 1.6× 13 887
Nataliia Beztsinna Netherlands 17 280 0.7× 90 0.4× 290 1.7× 202 1.5× 121 1.0× 30 801
Akshay Jain United States 16 503 1.2× 152 0.7× 271 1.6× 65 0.5× 62 0.5× 21 993
Mamoru Hatakeyama Japan 14 506 1.2× 68 0.3× 149 0.9× 82 0.6× 72 0.6× 31 740

Countries citing papers authored by Houzong Yao

Since Specialization
Citations

This map shows the geographic impact of Houzong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houzong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houzong Yao more than expected).

Fields of papers citing papers by Houzong Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houzong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houzong Yao. The network helps show where Houzong Yao may publish in the future.

Co-authorship network of co-authors of Houzong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Houzong Yao. A scholar is included among the top collaborators of Houzong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houzong Yao. Houzong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Fengling, Miaomiao Li, Huimin Zhang, et al.. (2025). Organelle-targeted BODIPY-conjugated platinum(iv) anticancer prodrugs for overcoming drug resistance. Dalton Transactions. 54(14). 5849–5858. 1 indexed citations
2.
Sun, Guohan, Gongyuan Liu, Shu Chen, et al.. (2025). Harnessing platinum(IV) prodrugs as versatile photoinitiators and photocrosslinkers for multifunctional hydrogels and protein labeling. Nature Communications. 16(1). 8879–8879.
3.
Chen, Shu, Peng Wang, Houzong Yao, et al.. (2025). Reactive Cysteines in Proteins are the Dominant Reductants for Platinum(IV) Prodrug Activation in Live Cells. Angewandte Chemie International Edition. 64(25). e202416396–e202416396. 1 indexed citations
4.
Liu, Gongyuan, Yachao Zhang, Houzong Yao, et al.. (2023). An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy. Science Advances. 9(25). eadg5964–eadg5964. 65 indexed citations
5.
Cui, Hao, et al.. (2023). Five Sesquiterpenes from Paraconiothyrium sp. and Their Anti‐inflammatory Activity. Chemistry & Biodiversity. 20(6). e202300477–e202300477. 3 indexed citations
6.
Wu, Junling, et al.. (2023). Trichodermic acids from an endophytic Trichoderma sp. and their antifungal activity against the phytopathogen Botrytis cinerea. Phytochemistry Letters. 56. 24–29. 2 indexed citations
7.
Bi, Yufang, et al.. (2023). Terpenoids from the endophytic fungus Microdiplodia sp. and their anti-inflammatory activities. Fitoterapia. 171. 105711–105711. 2 indexed citations
8.
Yao, Houzong & Guangyu Zhu. (2022). Blood Components as Carriers for Small‐Molecule Platinum Anticancer Drugs. ChemMedChem. 17(23). e202200482–e202200482. 3 indexed citations
9.
Liu, Yanpeng, Houzong Yao, Man‐Kit Tse, et al.. (2022). Synthesis, Characterization, and Cytotoxicity of a Reactive Platinum(IV) Monotrifluoromethyl Complex. European Journal of Inorganic Chemistry. 26(3).
10.
Yao, Houzong, Zhigang Wang, Na Wang, et al.. (2022). Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte‐Anchored Prodrug Strategy. Angewandte Chemie. 134(25). 5 indexed citations
11.
Yao, Houzong & Guangyu Zhu. (2022). A platinum-based fluorescent “turn on” sensor to decipher the reduction of platinum(iv) prodrugs. Dalton Transactions. 51(14). 5394–5398. 10 indexed citations
12.
Yao, Houzong, Zhigang Wang, Na Wang, et al.. (2022). Enhancing Circulation and Tumor Accumulation of Carboplatin via an Erythrocyte‐Anchored Prodrug Strategy. Angewandte Chemie International Edition. 61(25). 26 indexed citations
13.
Yao, Houzong, et al.. (2021). Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(iv) anticancer prodrugs. Dalton Transactions. 50(39). 13737–13747. 18 indexed citations
14.
Chen, Shu, et al.. (2021). The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(iv) prodrugs. Dalton Transactions. 51(3). 885–897. 7 indexed citations
15.
Yao, Houzong, Shu Chen, Zhiqin Deng, et al.. (2020). BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity. Inorganic Chemistry. 59(16). 11823–11833. 61 indexed citations
17.
Yao, Houzong, et al.. (2016). Antischistosomal activity of N,N′-arylurea analogs against Schistosoma japonicum. Bioorganic & Medicinal Chemistry Letters. 26(5). 1386–1390. 18 indexed citations
18.
Yao, Houzong, Feng Jiang, Aiping Lü, & Ge Zhang. (2016). Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs). International Journal of Molecular Sciences. 17(2). 194–194. 64 indexed citations
19.
Lü, Jun, Houzong Yao, Xiaoqing Lv, et al.. (2016). Prodrug Strategies for Paclitaxel. International Journal of Molecular Sciences. 17(5). 796–796. 68 indexed citations
20.
Yang, Jingjing, Jérôme Boissier, Jinglei Chen, et al.. (2015). Design, Synthesis and Biological Evaluation of Praziquantel and Endoperoxide Conjugates as Antischistosomal Agents. Future Medicinal Chemistry. 7(6). 713–725. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026